Des-gamma-carboxy prothrombin (DCP) as a biomarker for treatment response in hepatocellular carcinoma.

被引：1
|
作者：
Conner, Elizabeth
Chang, Jeremy
Burgoyne, Adam
机构：
[1] Univ Calif San Diego, San Diego, CA USA
[2] Univ Calif San Diego, La Jolla, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 3_SUPPL期
关键词：
283-424-425; 613-3267-9109-8855-5546; 130-540-543-4790; 613-135-2370-5109; 298-145-222-184-4809; 5; 4; 3; 2; 1854; 182; 7; 6;
D O I：
10.1200/JCO.2024.42.3_suppl.547
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：547 / 547
页数：1
相关论文
共 50 条
  • [41] THE DIAGNOSTIC-VALUE OF THE ASSAY OF DES-GAMMA-CARBOXY PROTHROMBIN IN THE DETECTION OF SMALL HEPATOCELLULAR-CARCINOMA
    CHAN, CY
    LEE, SD
    WU, JC
    LIN, HC
    HUANG, YS
    LO, GH
    LEE, FY
    TSAI, YT
    LO, KJ
    JOURNAL OF HEPATOLOGY, 1991, 13 (01) : 21 - 24
  • [42] SIGNIFICANCE OF SERUM ALPHA-FETOPROTEIN (AFP) AND DES-GAMMA-CARBOXY PROTHROMBIN (DCP) LEVELS TO IDENTIFY TREATMENT FAILURE AND CONTRAINDICATION FOR HEPATECTOMY IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC)
    Yamamoto, Kentaroh
    Imamura, Hiroshi
    Aoki, Taku
    Beck, Yoshifumi
    Hasegawa, Kiyoshi
    Sugawara, Yasuhiko
    Makuuchi, Masatoshi
    Kokudo, Norihiro
    HEPATOLOGY, 2010, 52 (04) : 1192A - 1192A
  • [43] Significance of Des-Gamma-Carboxy Prothrombin in Selection Criteria for Living Donor Liver Transplantation for Hepatocellular Carcinoma
    Fujiki, M.
    Takada, Y.
    Ogura, Y.
    Oike, F.
    Kaido, T.
    Teramukai, S.
    Uemoto, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (10) : 2362 - 2371
  • [44] Different Characteristics of Serum Alfa Fetoprotein and Serum Des-gamma-carboxy Prothrombin in Resected Hepatocellular Carcinoma
    Hayashi, Masamichi
    Yamada, Suguru
    Takano, Nao
    Okamura, Yukiyasu
    Takami, Hideki
    Inokawa, Yoshikuni
    Sonohara, Fuminori
    Tanaka, Nobutake
    Shimizu, Dai
    Hattori, Norifumi
    Kanda, Mitsuro
    Tanaka, Chie
    Nakayama, Goro
    Koike, Masahiko
    Kodera, Yasuhiro
    IN VIVO, 2021, 35 (03): : 1749 - 1760
  • [45] Des-g-carboxy Prothrombin (DCP) Is Produced by Overexpression of Prothrombin Gene in Hepatocellular Carcinoma
    Taniguchi, Tatsuya
    Tanaka, Hironori
    Tanaka, Takahiro
    Tomonari, Tetsu
    Kishi, Kazuhiro
    Miyamoto, Hiroshi
    Muguruma, Naoki
    Sogabe, Masahiro
    Nakagawa, Tadahiko
    Takayama, Tetsuji
    GASTROENTEROLOGY, 2016, 150 (04) : S517 - S518
  • [46] Measurement of des-gamma-carboxy prothrombin levels in cancer and non-cancer tissue in patients with hepatocellular carcinoma
    Yuan, LW
    Tang, W
    Kokudo, N
    Sugawara, Y
    Karako, H
    Hasegawa, K
    Aoki, T
    Kyoden, Y
    Deli, G
    Li, YG
    Makuuchi, M
    ONCOLOGY REPORTS, 2004, 12 (02) : 269 - 273
  • [47] Vitamin K2 Inhibits the Growth of Hepatocellular Carcinoma via Decrease of Des-Gamma-Carboxy Prothrombin
    Ma, Meng
    Qu, Xian-Jun
    Mu, Guo-Ying
    Chen, Ming-Hui
    Cheng, Yan-Na
    Kokudo, Norihiro
    Tang, Wei
    Cui, Shu-Xiang
    CHEMOTHERAPY, 2009, 55 (01) : 28 - 35
  • [48] Des-gamma-carboxy prothrombin (DCP) level is a strong factor to predict the prognosis of advanced stage of hepatocellular carcinoma patients treated by chemolipiodolization or chemotherapy only.
    Ohnishi, H
    Sakaguchi, K
    Nishda, T
    Iwadou, S
    Shoji, B
    Tanaka, H
    Nakamura, S
    Kobayashi, Y
    Noose, K
    Shiratori, Y
    GASTROENTEROLOGY, 2005, 128 (04) : A453 - A453
  • [49] Living donor liver transplantation for hepatocellular carcinoma: A special reference to a preoperative des-gamma-carboxy prothrombin value
    Shimada, M
    Yonemura, Y
    Ijichi, H
    Harada, N
    Shiotani, S
    Ninomiya, M
    Terashi, T
    Yoshizumi, T
    Soejima, Y
    Maehara, Y
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) : 1177 - 1179
  • [50] STUDY OF PRODUCTION OF DES-GAMMA-CARBOXY PROTHROMBIN BY HEPATOCELLULAR-CARCINOMA USING A NUDE-MOUSE MODEL
    YAMAGATA, H
    NAKANISHI, T
    OKUDA, H
    OBATA, H
    HEPATOLOGY, 1992, 16 (02) : 608 - 608
12345